Dr. Kimberly E. Wooten, MD

Dr. Wooten practices at Roswell Park Cancer Institute in Los Angeles, California.

Dr. Wooten's NPI, 1235390949, was assigned on June 24, 2008. Dr. Wooten graduated from University Of Florida College Of Medicine in 2008. Dr. Wooten holds New York license 276680.

Dr. Wooten's primary practice is Roswell Park Cancer Institute, at 344 S Hauser Blvd, Los Angeles, CA 90036 in Los Angeles County. The practice phone is (716) 845-2300.

Dr. Wooten's primary practice is Roswell Park Cancer Institute in Los Angeles, California. Dr. Wooten is also affiliated with Roswell Park Comprehensive Cancer Center. The medical group on file is Roswell Park Comprehensive Cancer Center.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wooten practices. Vendor and product names are available with a free account.

Surgery is Dr. Wooten's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Wooten is licensed in New York.

CMS data shows 39 Medicare services from Dr. Wooten across 1 procedure code in 2024, all of them office visits, for 79 Medicare patients. Medicare paid $991 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 79 Medicare patients who saw Dr. Wooten in 2024. The largest group is 65 to 74, with 31 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 22% are also on Medicaid. Their average risk score is 1.68, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Wooten's median patient age at 70, with 59% women.

In 2024, Dr. Wooten wrote 69 Medicare Part D claims for 34 patients. 100% of them were for generic drugs. CMS names the drug for 28 of them, across 2 drugs with 11 or more claims each, at $533 in total drug cost. In 2023, CMS named 21 claims across 1 drug.

Dr. Wooten accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Wooten as offering telehealth.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 27 papers to Dr. Wooten, published from 2011 to 2025. 2021 was the busiest year, with 5. The most frequent topics are Head and Neck Neoplasms, Chemoradiotherapy and Papillomavirus Infections. Dr. Wooten has published most often in Oral Oncol. Dr. Wooten's most frequent co-authors are Vishal Gupta, MD, Wesley L. Hicks, MD and Austin James Iovoli, MD.

CMS Open Payments shows 7 general payments to Dr. Wooten from 4 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 65% of the total. Integra LifeSciences Corporation paid the most, $325.

Dr. Wooten graduated from University Of Florida College Of Medicine in 2008.